BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3801956)

  • 21. [A case of malignant hyperthermia; successful treatment with intravenous dantrolene sodium].
    Noda B; Higa K; Naitoh H; Dan K
    Masui; 1985 Jun; 34(6):822-7. PubMed ID: 4032707
    [No Abstract]   [Full Text] [Related]  

  • 22. [On the treatment of malignant hyperthermia. A simple method of preparing a dantrolene sodium solution (author's transl)].
    Drechsler H
    Anaesthesist; 1981 May; 30(5):257-8. PubMed ID: 7247013
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of malignant hyperthermia with dantrolene].
    Landauer B
    Anaesthesist; 1980 Sep; 29(9):507-8. PubMed ID: 7468992
    [No Abstract]   [Full Text] [Related]  

  • 24. [Malignant hyperthermia. Current aspects of dantrolene treatment of 2 cases of hyperthermia maligna incipiens].
    Hoffmann-Lundgren B; Kühn K; Hausdörfer J
    Anasth Intensivther Notfallmed; 1982 Jun; 17(3):169-70. PubMed ID: 7125160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of malignant hyperthermia with dantrolene.
    Cooper JM; Jones HR; Williamson JW
    J Miss State Med Assoc; 1983 Oct; 24(10):259-61. PubMed ID: 6644804
    [No Abstract]   [Full Text] [Related]  

  • 26. Dantrolene for malignant hyperthermia during anesthesia.
    Med Lett Drugs Ther; 1980 Jul; 22(15):61-2. PubMed ID: 7393124
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of azumolene on normal and malignant hyperthermia-susceptible skeletal muscle.
    Sudo RT; Carmo PL; Trachez MM; Zapata-Sudo G
    Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):308-16. PubMed ID: 18047479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dantrolen solution of high active substance concentration. Preliminary communication (author's transl)].
    Rommelsheim K; Lauven P; Westhofen P; Stenger I; Stoeckel H
    Anasth Intensivther Notfallmed; 1980 Oct; 15(5):423-7. PubMed ID: 6779658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Malignant hyperthermia. Physiologic and genetic principles].
    Ecker-Schlipf B
    Med Monatsschr Pharm; 1993 Jan; 16(1):18-9. PubMed ID: 8433672
    [No Abstract]   [Full Text] [Related]  

  • 30. [Malignant hyperthermia induced by neuroleptics. Rapid cure with dantrolene].
    Boles JM; Lecam B; Mialon P; Pennec Y; Garre M
    Nouv Presse Med; 1982 Feb; 11(9):674. PubMed ID: 6122201
    [No Abstract]   [Full Text] [Related]  

  • 31. Current concepts. The malignant hyperthermia syndrome.
    Nelson TE; Flewellen EH
    N Engl J Med; 1983 Aug; 309(7):416-8. PubMed ID: 6348539
    [No Abstract]   [Full Text] [Related]  

  • 32. Dantrolene sodium in the treatment of malignant hyperthermia. A case report.
    Harrison GG
    S Afr Med J; 1981 Dec; 60(23):909-10. PubMed ID: 7302773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dantrolene plasma and urine concentrations after oral pretreatment for malignant hyperthermia: report of a case.
    Wuis EW; Driessen JJ; Evers J; Vree TB; van der Kleyn E
    Eur J Anaesthesiol; 1986 May; 3(3):219-23. PubMed ID: 3780690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful use of dantrolene sodium in human malignant hyperthermia syndrome: a case report.
    Friesen CM; Brodsky JB; Dillingham MF
    Can Anaesth Soc J; 1979 Jul; 26(4):319-21. PubMed ID: 509349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Capnography and anesthetic-induced malignant hyperthermia].
    Krivosic-Horber R; Theunynck D; Adnet P
    Agressologie; 1985 Nov; 26(11):929-32. PubMed ID: 3938623
    [No Abstract]   [Full Text] [Related]  

  • 36. Dantrolene sodium in the treatment of malignant hypertension.
    Harrison GG; Chapman DC
    S Afr Med J; 1982 Oct; 62(15):503-4. PubMed ID: 7123413
    [No Abstract]   [Full Text] [Related]  

  • 37. [Malignant hyperthermia].
    Solera J; Rallo B
    Med Clin (Barc); 1985 Oct; 85(10):431-2. PubMed ID: 4079503
    [No Abstract]   [Full Text] [Related]  

  • 38. Malignant hyperthermia: current perspectives.
    Felice-Johnson J; Sudds T; Bennett G
    Am J Hosp Pharm; 1981 May; 38(5):646-51. PubMed ID: 7282692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium. 1975.
    Harrison GG
    Br J Anaesth; 1998 Oct; 81(4):626-9; discussion 625. PubMed ID: 9924249
    [No Abstract]   [Full Text] [Related]  

  • 40. Malignant hyperthermia: are we really prepared?
    Hein HA; Roewer N; Jantzen JP
    Anesthesiology; 1987 Mar; 66(3):448-9. PubMed ID: 3826723
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.